WBG
Wharton Business Group’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,220
| Closed | -$200K | – | 92 |
|
2021
Q2 | $200K | Buy |
+1,220
| New | +$200K | 0.02% | 116 |
|
2020
Q3 | – | Sell |
-2,635
| Closed | -$360K | – | 113 |
|
2020
Q2 | $360K | Buy |
2,635
+250
| +10% | +$34.2K | 0.03% | 82 |
|
2020
Q1 | $257K | Sell |
2,385
-1,635
| -41% | -$176K | 0.03% | 86 |
|
2019
Q4 | $484K | Buy |
4,020
+1,950
| +94% | +$235K | 0.05% | 69 |
|
2019
Q3 | $206K | Hold |
2,070
| – | – | 0.02% | 97 |
|
2019
Q2 | $226K | Buy |
2,070
+195
| +10% | +$21.3K | 0.02% | 92 |
|
2019
Q1 | $210K | Buy |
+1,875
| New | +$210K | 0.02% | 95 |
|
2018
Q4 | – | Sell |
-1,875
| Closed | -$229K | – | 99 |
|
2018
Q3 | $229K | Hold |
1,875
| – | – | 0.02% | 95 |
|
2018
Q2 | $205K | Hold |
1,875
| – | – | 0.02% | 98 |
|
2018
Q1 | $200K | Hold |
1,875
| – | – | 0.02% | 98 |
|
2017
Q4 | $200K | Buy |
1,875
+1,250
| +200% | +$133K | 0.02% | 104 |
|
2017
Q3 | $208K | Buy |
+625
| New | +$208K | 0.02% | 105 |
|
2016
Q3 | – | Sell |
-1,825
| Closed | -$470K | – | 119 |
|
2016
Q2 | $470K | Hold |
1,825
| – | – | 0.06% | 97 |
|
2016
Q1 | $476K | Buy |
+1,825
| New | +$476K | 0.05% | 98 |
|
2015
Q4 | – | Sell |
-1,825
| Closed | -$554K | – | 128 |
|
2015
Q3 | $554K | Buy |
+1,825
| New | +$554K | 0.05% | 98 |
|
2015
Q2 | – | Sell |
-1,825
| Closed | -$627K | – | 138 |
|
2015
Q1 | $627K | Hold |
1,825
| – | – | 0.05% | 106 |
|
2014
Q4 | $554K | Hold |
1,825
| – | – | 0.05% | 108 |
|
2014
Q3 | $499K | Hold |
1,825
| – | – | 0.04% | 122 |
|
2014
Q2 | $469K | Hold |
1,825
| – | – | 0.05% | 116 |
|
2014
Q1 | $431K | Buy |
+1,825
| New | +$431K | 0.03% | 127 |
|
2013
Q4 | – | Sell |
-1,825
| Closed | -$383K | – | 152 |
|
2013
Q3 | $383K | Hold |
1,825
| – | – | 0.03% | 123 |
|
2013
Q2 | $317K | Buy |
+1,825
| New | +$317K | 0.03% | 128 |
|